Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 15.05.2024
MAX Automation SE
Muted start into the year but solid order intake; chg. est.
Topic: MAX released mixed Q1 results with muted sales and slight pressure
on margins in line with expectations. However, order intake moderately
improved qoq from a low level in the last three quarters
supported by continuous follow-up orders from ELWEMA.
Q1 group sales declined slig [ … ]
Tue, 14.05.2024
A.H.T. Syngas Technology N.V.
- Growth strategy to become a multinational CleanTec and clean energy
providers
- Financial year 2023 successfully concluded with record sales, record
earnings and a promising backlog according to preliminary figures
AHT Syngas Technology N.V. (AHT) is a global company that develops
technologies for converting carbon-based fuels into synth [ … ]
Tue, 14.05.2024
CR Energy AG
Final FY slightly ahead of preliminary figures / chg.
CR Energy published its FY ’23 report, displaying figures slightly ahead of
the prelims published in March. In detail:
FY ’23 sales, which refers mainly to income from the investment business,
came in at € 68.8m, implying a 14% yoy decline. The decline can be mainly
explai [ … ]
Tue, 14.05.2024
Flughafen Wien AG
Q1 preview: record top and bottom line ahead
Topic: FWAG's Q1 results are due on Thursday, May 16th and we expect solid
top-line growth and proportionate EBITDA growth, while EBIT and net income
should show disproportionate growth and should mark new record levels. In
detail:
Sales should grow by 17% yoy to € 212m (eCons: € 212m), d [ … ]
Tue, 14.05.2024
q.beyond AG
Strong Q1 figures hint towards successful transformation/ chg.
Yesterday, q.beyond released a strong set of Q1 figures, which exceeded
ours and streets profitability estimates as efficiency measures bore fruit
despite rather muted top-line growth. In detail:
Q1 sales increased slightly by 1.1% yoy to € 47.1m (eNuW: €47.5m, eCons: &e [ … ]
Mon, 13.05.2024
Schloss Wachenheim AG
First Berlin Equity Research has published a research update on Schloss
Wachenheim AG (ISIN: DE0007229007). Analyst Simon Scholes reiterated his
BUY rating and maintained his EUR 22.00 price target.
Abstract:
Q3 23/24 sales climbed 5.6% to €87.1m (Q3 22/23: €82.5m) as price rises and
positive product mix and currency effects outweighe [ … ]
Mon, 13.05.2024
LION E-Mobility AG
CMD underpins promising mid-term prospects; chg
Q1 sales came in at a mere € 1.2m with an EBITDA of € -2.6m. This is a
significant decrease compared to the particularly strong Q4 last year with
roughly € 26m sales and € 1m EBITDA. As pointed out during the earnings
call, this should mainly be driven by the seasonal distribut [ … ]
Mon, 13.05.2024
MLP SE
Q1 preview: performance fees and banking to drive EBIT
Topic: MLP's Q1 results are due on Wednesday, May 15th and we expect a
solid EBIT expansion driven by a contribution of performance fees (first
time since Q4'21) as well as continuous support from the banking business.
In detail:
Solid top-line: For Q1, we expect sales to grow by 7% to &e [ … ]
Mon, 13.05.2024
Multitude SE
Solid Q1 figures ahead // Multitude to continue on growth path
On Thursday, Multitude will report Q1´24 figures that should come in solid,
but with room for sequential improvements until YE. Here is what to expect:
Sales should come in at € 59m (+9% yoy, -6% qoq), mainly driven by the
strong growth of the net loan book (NAR) to &eu [ … ]
Fri, 10.05.2024
MPH Health Care AG
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG
(ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 62,00 auf EUR 81,00.
Zusammenfassung:
Die vorläufigen Ergebnisse entsprachen weitgehend unseren Erwartungen. Der
JE23 Nettoinventa [ … ]